BNF:

4.8.1

Status:

Do Not Prescribe (DNP), Green, Green - after consultant/specialist initiation

Decision Date:

August 2013

Comments

GREEN after consultant/specialist initiation: for epilepsy

GREEN:  3rd line for neuropathic pain (Decision date - April 2023). See guideline for managing neuropathic pain in primary care

DO NOT PRESCRIBE (DNP): Neurontin brand is BLACK for non-epilepsy conditions. (Decision date - August 2019)

search again